Ascendis Pharma AS (NASDAQ: ASND) stock closed at $142.49 on 2/13/25 after a major increase of 13.0%. Moreover, trading volume in this advance was exceptionally high at 343% of normal. The stock has performed in line with the market over the last nine months and has risen 10.1% during the last week.
Current PriceTarget Research Rating
Ascendis Pharma AS is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment